South Korea secures 30 million Pfizer doses for 2022 booster campaign
South Korea has signed a contract with Pfizer to purchase 30 million doses of the Pfizer–BioNTech COVID-19 vaccine for use in 2022 as part of a plan to administer 50 million booster shots.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan for full access to every Belfast Herald story and the complete archive.
HealthSouth Korea secures 30 million Pfizer doses for 2022 booster campaign
Sign in or subscribeBrowse free archive reportsSouth Korea has signed a contract with Pfizer to purchase 30 million doses of the Pfizer–BioNTech COVID-19 vaccine for use in 2022 as part of a plan to administer 50 million booster shots.